Navigation Links
Combined therapy could repair and prevent damage in Duchenne muscular dystrophy
Date:8/9/2013

New research on two promising gene therapies suggests that combining them into one treatment not only repairs muscle damage caused by Duchenne muscular dystrophy, but also prevents future injury from the muscle-wasting disease. The work, led by a team at The Research Institute at Nationwide Children's Hospital, is the first to look at the approach in aged mice, a key step toward clinical trials in patients. The findings were published in July in Human Molecular Genetics.

"We're excited about the fact that these are older mice and we're still able to see a sustained functional benefit from this combined therapythis hasn't been shown before," says Louise Rodino-Klapac, PhD, a principle investigator in the Center for Gene Therapy at Nationwide Children's and lead author of the research.

Duchenne muscular dystrophy (DMD) is the most common form of muscular dystrophy in children, affecting about one out of every 3,500 to 6,000 male births. Symptoms usually begin between the ages of 3 and 5 years and progress rapidly. Most patients are unable to walk by age 12 and ultimately need a respirator to breathe.

Patients with DMD lack the gene that makes dystrophin, a protein vital for healthy muscle tissue. Dystrophin acts as an anchor to support muscle fiber strength and prevent injury. Without it over time, the muscle degenerates, scar tissue builds up and fat slowly replaces the dead muscle. The gene that produces dystrophin is hugethe largest known gene in the bodyso a much smaller version, called micro-dystrophin, has been developed for gene replacement therapeutic studies.

Another gene replacement therapy currently under study in patients with different forms of muscular dystrophy is follistatin 344, which produces a protein that enhances muscle strength and prevents atrophy.

While preliminary studies in animals of each of these therapies suggest they offer some benefit when used individually, the team at Nationwi
'/>"/>

Contact: Gina Bericchia
Gina.Bericchia@NationwideChildrens.org
614-355-0495
Nationwide Children's Hospital
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Neural stem cell transplants for spinal cord injury maximized by combined, complimentary therapies
2. Combined pesticide exposure affects bumblebee colony success
3. Synthetic and biological nanoparticles combined to produce new metamaterials
4. Stanford scientists develop gene therapy approach to grow blood vessels in ischemic limbs
5. Ottawa researchers to lead world-first clinical trial of stem cell therapy for septic shock
6. New insight into mechanisms behind autoimmune diseases suggests a potential therapy
7. The Japanese traditional therapy, honokiol, blocks key protein in inflammatory brain damage
8. Researchers discover novel therapy for Crohns disease
9. Nanotherapy: Treating deadly brain tumors by delivering big radiation with tiny tools
10. Cell therapy using patients own bone marrow may present option for heart disease
11. Harmless human virus may be able to boost the effects of chemotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... DUBLIN , May 28, 2015 ... the addition of the "Facial Recognition Market ... User - Global Forecast to 2020" report ... years, have seen facial recognition technology become more ... technology to gain traction and investment from the ...
(Date:5/27/2015)... , May 27, 2015   Codonics ... safety systems and image documentation solutions and ... comprehensive, technologically-advanced automation solutions, is pleased to ... The Codonics® Safe Label System® (SLS), an ... conjunction with the Omnicell Anesthesia Workstation, helps ...
(Date:5/25/2015)... 2015  Australia,s market for wearable technologies is considered ... the advent of several trials and prototypes. The release ... expected to ignite interest in wearables as well as ... . This in turn will spur greater innovation ... partnerships amongst vendors and distributors. Photo ...
Breaking Biology News(10 mins):Global advanced Facial Recognition Market Expected to Grow From $2.77 Billion in 2015 to $6.19 Billion in 2020, at an Estimated CAGR of 17.4% 2Codonics and Omnicell Expand Partnership 2Codonics and Omnicell Expand Partnership 3Codonics and Omnicell Expand Partnership 4Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 2Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 3Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 4
... . Vitamin B12 is vital for cell division, the ... system. Unable to produce the vitamin itself, the human body has ... known that on its way into the cell vitamin B12 is ... the cell interior with the aid of the transport protein CblF, ...
... Department of Energy,s Lawrence Berkeley National Laboratory (Berkeley Lab) found ... improved sperm DNA quality in older men. In younger men, ... DNA. In an analysis of 80 healthy male volunteers ... that men older than 44 who consumed the most vitamin ...
... California Institute of Technology (Caltech) have made the first-ever ... molecules one at a time. This new ... diseases, enable biologists to study viruses and probe the ... better measure nanoparticles and air pollution. The ...
Cached Biology News:Vitamin B12 deficiency: Tracing the causes 2Nutrition tied to improved sperm DNA quality in older men 2Nutrition tied to improved sperm DNA quality in older men 3Weighing molecules 1 at a time 2Weighing molecules 1 at a time 3Weighing molecules 1 at a time 4
(Date:6/3/2015)... DUBLIN , June 02, 2015 /PRNewswire/ ... has announced the addition of the ... Testing Market" report to their offering. ... analysis of the US immunoprotein diagnostic market, ... market shares, and strategic profiles of leading ...
(Date:6/3/2015)... -- Findings presented at the European Organization ... of NeuroOncology (EANO) and European Society for Medical Oncology ... that EDO-S101 is effective in models of human glioblastoma ... radiotherapy (RT). [ 1 ] ... that combines the DNA damaging effect of bendamustine with ...
(Date:6/3/2015)... 2015 On April 21, 2015, California ... Communications Committee (11-0) and indicates the legislature's desire to support ... , The Committee Chairman supports the bill and would like ... 8,000 GWh and would also like to see any new ... This “Wait List” and timing are extremely important. , To ...
(Date:6/3/2015)... 2015 Typical racks for laboratory freezers ... and depths often taking up unnecessary room in already ... Low 5 Box Freezer Racks offer a customizable ... freezer storage boxes and freezers. , “These racks ... experiments or multiple people because users can configure freezer ...
Breaking Biology Technology:United States Strategies in the Immunoprotein Diagnostic Testing Market Report 2015 2Mundipharma EDO GmbH Data Confirm EDO-S101 is Effective in Preclinical Models of Human Glioblastoma 2Mundipharma EDO GmbH Data Confirm EDO-S101 is Effective in Preclinical Models of Human Glioblastoma 3Mundipharma EDO GmbH Data Confirm EDO-S101 is Effective in Preclinical Models of Human Glioblastoma 4Bmark Energy Announces the Sign-up Deadline for Companies Interested in California’s Direct Access Program is June 12th, 2015 at 5:00pm. 2Freezer Space Can Now Be Configured Your Way with New Modular Freezer Racks 2
... , BEIJING, China , July 6 ... the development, assembly,marketing and sale of medical devices and homecare medical products in ... EPS for,fiscal year 2010. , , ... (Logo: http://photos.prnewswire.com/prnh/20100422/CNTH001LOGO ) , ...
... Cellectis (Alternext: ALCLS), the French genome engineering specialist, announced today ... by Taconic Artemis and Taconic Farms Inc in December 2008 ... , , , ... of the Tribunal de Grande Instance decided on Tuesday, June 29 ...
... July 6 Novavax, Inc. (Nasdaq: NVAX ... M.D., as the company,s Chief Scientific Officer who will report ... Officer of Novavax.  Previously, Dr. Glenn was Chief Scientific Officer ... international health at Johns Hopkins University,s School of Public ...
Cached Biology Technology:Dehaier Medical Systems Reaffirms Earnings Estimate of $0.80 EPS for FY 2010 2Dehaier Medical Systems Reaffirms Earnings Estimate of $0.80 EPS for FY 2010 3Dehaier Medical Systems Reaffirms Earnings Estimate of $0.80 EPS for FY 2010 4Taconic's Litigation Contesting License Termination By Cellectis Is Dismissed 2Taconic's Litigation Contesting License Termination By Cellectis Is Dismissed 3Novavax Announces Appointment of Dr. Gregory Glenn as Chief Scientific Officer 2Novavax Announces Appointment of Dr. Gregory Glenn as Chief Scientific Officer 3Novavax Announces Appointment of Dr. Gregory Glenn as Chief Scientific Officer 4